California Public Employees Retirement System Relmada Therapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$29.55 - $39.15 $868,770 - $1.15 Million
-29,400 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$31.52 - $39.28 $83,654 - $104,249
-2,654 Reduced 8.28%
29,400 $1.04 Million
Q4 2020

Feb 02, 2021
SELL
$29.88 - $39.8 $17,928 - $23,880
-600 Reduced 1.84%
32,054 $1.03 Million
Q3 2020

Nov 05, 2020
BUY
$34.42 - $43.78 $25,815 - $32,835
750 Added 2.35%
32,654 $1.23 Million
Q2 2020

Aug 12, 2020
BUY
$31.59 - $49.98 $1.01 Million - $1.59 Million
31,904 New
31,904 $1.43 Million

Others Institutions Holding RLMD

# of Institutions
81
Shares Held
12.3M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.3M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email